Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.39 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.39 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.39 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.39 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.39 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25430781 | 0.86 | ALDH1A1 (0.44) | ALDH1A1TSHRKCNN4CYP2C19HIF1A | |
| SCHEMBL5962490 | 0.81 | HTT (0.46) | ALDH1A1TSHRKCNN4CYP2C19HIF1A | |
| SCHEMBL11265555 | 0.81 | ALDH1A1 (0.38) | ALDH1A1TSHRKCNN4CYP2C19HIF1A | |
| SCHEMBL28811606 | 0.80 | ALDH1A1 (0.40) | ALDH1A1TSHRKCNN4CYP2C19HIF1A | |
| SCHEMBL11379208 | 0.74 | CYP2C19 (0.52) | ALDH1A1TSHRKCNN4CYP2C19HIF1A | |
| SCHEMBL1096837 | 0.74 | KCNN4 (0.47) | ALDH1A1TSHRKCNN4CYP2C19HIF1A | |
| SCHEMBL5666953 | 0.74 | KCNN4 (0.47) | ALDH1A1TSHRKCNN4CYP2C19HIF1A | |
| SCHEMBL11019163 | 0.74 | MAPK1 (0.39) | ALDH1A1TSHRKCNN4HTTKMT2A | |
| SCHEMBL7123831 | 0.73 | TSHR (0.48) | ALDH1A1TSHRKCNN4HTTAKT1 | |
| SCHEMBL27570729 | 0.73 | CYP2C19 (0.47) | ALDH1A1TSHRKCNN4CYP2C19HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2001513805-A | — | — | 2001-09-04 | — | — | JP | claimed |
| EP-0968220-A1 | 6,6'-BIS-(1-PHOSPHANORBORNADIENE) DIPHOSPHINES | RHODIA CHIMIE (FR) | 2000-01-05 | — | — | EP | claimed |
| WO-1998039345-A1 | 6,6'-BIS-(1-PHOSPHANORBORNADIENE) DIPHOSPHINES | RHODIA CHIMIE (FR) | 1998-09-11 | — | — | WO | claimed |
| US-20090182153-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE ALLYL COMPOUND | NISSAN CHEMICAL INDUSTRIES, LTD (JP) | 2009-07-16 | — | — | US | disclosed |
| EP-1658298-A2 | NOVEL ORGANIC COMPOUNDS AND METAL COMPLEXES | Solvias AG (CH) | 2006-05-24 | — | — | EP | disclosed |
| WO-2005021562-A2 | PHOSPINITE-IMIDAZOLINES AND METAL COMPLEXES THEREOF | SOLVIAS AG (CH) | 2005-03-10 | — | — | WO | disclosed |
| EP-1064290-A1 | 1-PHOSPHANORBORNADIENES | RHODIA CHIMIE (FR) | 2001-01-03 | — | — | EP | disclosed |
| WO-1999047530-A1 | 1-PHOSPHANORBORNADIENES | RHODIA CHIMIE (FR) | 1999-09-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090182153-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE ALLYL COMPOUND | HRH4, OR10J3, RPS9 | ALDH1A1 837/4885TSHR 621/4885KCNN4 2110/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.